冲出重围,双免为剑直指恶性胸膜间皮瘤——评CheckMate 743研究

    Bursting Out of the Siege, the Double-Immunotherapy as Sword Is Directed at Malignant Pleural Mesothelioma

    /

    返回文章
    返回